Moving diagnostic frontiers in dermatology

Pioneering molecular tests to advance clinical practice and improve patients' lives

The demand for precision diagnostics

One third of the population suffers from at least one skin condition¹.

Skin diseases impair patients’ quality of life more drastically than cancer and diabetes²’³.

2.63 billion people suffer from at least one skin disease
Biologics and small-molecule inhibitors have created an unprecedented potential for precision medicine. Yet, diagnostics have not kept pace. Dermagnostix offers molecular diagnostic solutions to meet the need for personalized care.
Workflow Dermagnostix automated test

Your point-of-need molecular solution

Groundbreaking translational research meets cutting-edge technology – Dermagnostix provides unique diagnostic tests for unmet clinical needs in dermatology on a fully automated portable laboratory. With PsorX (CE-IVD), Dermagnostix offers the first in-class molecular test for differential diagnosis of psoriasis and eczema.

PsorX molecular test differential diagnosis psoriasis eczema
Slide 1
Prof. Denisa Kacerovská, M.D., PhD

Bioptická laboratoř s.r.o. Pilsen, Czech Republic

“Most of my routine cases are inflammatory diseases, especially eczema and psoriasis. Most of them are straightforward in diagnoses. However, some cause diagnostic dilemmas. In these cases, the PsorX-LabDisk is extremely useful in supporting my histological diagnosis quickly and easily. Furthermore, its user-friendly handling saves me time compared to other molecular biological tests.“

Slide 1
Prof. Kristian Reich, M.D., Ph.D

Specialist in dermatology and venereology
Professor for translational research of inflammatory skin diseases

“The molecular diagnostic possibilities Dermagnostix offers will be the future in pattern diagnostics of dermatological diseases and ultimately treatment selection. Great to see how the platform automizes complex procedures in a closed and fast system.“

Slide 3
Dr. Natalie Garzorz-Stark

CEO & Co-Founder Dermagnostix

"With the Dermagnostix system, we are proud to be the first to expand the sample-to-answer diagnostic options for inflammatory skin diseases to the molecular level, thus enabling patients with an ambiguous clinical picture to receive an objective diagnosis"

Slide 4
Innovative Molecular Diagnostics
for Dermatology

Don’t miss this opportunity to see how we’re revolutionizing molecular diagnostics. Be part of it and join our community of innovative pioneers who are shaping the molecular diagnostic future in dermatology!

previous arrowprevious arrow
next arrownext arrow

Simple diagnostic tools for complex skin diseases

Get diagnostic support for challenging skin diseases using our quick and simple system: Sample into LabDisk – LabDisk into Analyzer – Answer out.
Simple

Ensuring maximum usability, the user only needs to place the sample into the LabDisk and insert the LabDisk into the Analyzer.

Quick

Results are delivered in only 45 min to 2 hours enabling physicians to make timely decisions about their patients’ therapies.

Cost-efficient

Each LabDisk contains only minimum amounts of reagents and materials due to microfluidics design.

Precise

All advantages of centrifugal microfluidics are exploited, enabling reliable, objective and valid results.

Point of need

Timely diagnoses where they are needed: Get objective and valid results anywhere and at any time.

Product of Germany

Our technology is developed, produced and tested in Germany.

Upcoming Events

DermChange 2024


Maritim Hotel, Düsseldorf, Germany

October 11-13, 2024

More information

MEDICA 2024


Messe Düsseldorf, Germany

November 11-14, 2024

More information

24. Bundeskongress Pathologie

Hotel Titanic, Berlin, Germany

November 22-23, 2024

More information